0001493152-23-027579.txt : 20230810 0001493152-23-027579.hdr.sgml : 20230810 20230810163035 ACCESSION NUMBER: 0001493152-23-027579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230808 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOSKI ROBERT C CENTRAL INDEX KEY: 0001234880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 231160044 MAIL ADDRESS: STREET 1: 1500 W UNIVERSITY PARKWAY CITY: SARASOTA STATE: FL ZIP: 34243 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4 1 ownership.xml X0508 4 2023-08-08 0 0001174940 ORAGENICS INC OGEN 0001234880 KOSKI ROBERT C 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 0 Common Stock 2023-08-08 4 A 0 25000 0 A 25689 D Common Stock 18367 I See Footnote Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months. Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023. Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. /s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski 2023-08-10